Velichka Andonova

Prof. Velichka Andonova

Medical University of Varna, Varna, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Stefan Radnev StefanovStefan Radnev Stefanov
Stefan Radnev Stefanov
Velichka AndonovaVelichka Andonova
Velichka Andonova
The multifunctional role of the human skin is well known. It acts as a sensory and immune organ that protects the human body from harmful environmental impacts such as chemical, mechanical, and physical threats, reduces UV radiation effects, prevents moisture loss, and helps thermoregulation. In this regard, skin disorders related to skin integrity require adequate treatment. Lipid nanoparticles (LN) are recognized as promising drug delivery systems (DDS) in treating skin disorders. Solid lipid nanoparticles (SLN) together with nanostructured lipid carriers (NLC) exhibit excellent tolerability as these are produced from physiological and biodegradable lipids. Moreover, LN applied to the skin can improve stability, drug targeting, occlusion, penetration enhancement, and increased skin hydration compared with other drug nanocarriers. Furthermore, the features of LN can be enhanced by inclusion in suitable bases such as creams, ointments, gels (i.e., hydrogel, emulgel, bigel), lotions, etc. This review focuses on recent developments in lipid nanoparticle systems and their application to treating skin diseases. We point out and consider the reasons for their creation, pay attention to their advantages and disadvantages, list the main production techniques for obtaining them, and examine the place assigned to them in solving the problems caused by skin disorders.

13 February 2019
Verified
Book Chapter
Open access
PDF file
Nadezhda IvanovaNadezhda Ivanova
Nadezhda Ivanova
Viliana GuglevaViliana Gugleva
Viliana Gugleva
MDMirena Dobreva
Mirena Dobreva
IPIvaylo Konstantinov Pehlivanov
Ivaylo Konstantinov Pehlivanov
Stefan Radnev StefanovStefan Radnev Stefanov
Stefan Radnev Stefanov
Velichka AndonovaVelichka Andonova
Velichka Andonova
Nanoparticles can surmount some essential problems of conventional small molecules or biomacromolecules (e.g., DNA, RNA, and protein) used in some diseases by allowing targeted delivery and overcome through biological barriers. Recently, silver nanoparticles have been harnessed as delivery vehicles for therapeutic agents, including antisense oligonucleotides, and other small molecules. Silver is the most profit-oriented precious metal used in the preparation of nanoparticles and nanomaterials because of its antibacterial, antiviral, antifungal, antioxidant and unusually enhanced physicochemical properties compared to the bulk material such as optical, thermal, electrical, and catalytic properties. Small silver nanoparticles offer many advantages as drug carriers, including adjustable size and shape, enhanced stability of surface-bound nucleic acids, high-density surface ligand attachment, transmembrane delivery without harsh transfection agents, protection of the attached therapeutics from degradation, and potential for improved timed/controlled intracellular drug-delivery. Plant-mediated synthesis of silver nanoparticles is gaining interest due to its inexpensiveness, providing a healthier work environment, and protecting human health leading to lessening waste and safer products. The chapter presents the essential physicochemical characteristics, antibacterial, and anticancer properties which silver nanoparticles obtained by plant-mediated methods possess, and their application as drug-delivery systems with a critical view on the possible toxicity on the human body.

22 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Viliana GuglevaViliana Gugleva
Viliana Gugleva
Velichka AndonovaVelichka Andonova
Velichka Andonova
Sufficient ocular bioavailability is often considered a challenge by the researchers, due to the complex structure of the eye and its protective physiological mechanisms. In addition, the low viscosity of the eye drops and the resulting short ocular residence time further contribute to the observed low drug concentration at the target site. Therefore, various drug delivery platforms are being developed to enhance ocular bioavailability, provide controlled and sustained drug release, reduce the number of applications, and maximize therapy outcomes. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) exhibit all these benefits, in addition to being biocompatible, biodegradable, and susceptible to sterilization and scale-up. Furthermore, their successive surface modification contributes to prolonged ocular residence time (by adding cationic compounds), enhanced penetration, and improved performance. The review highlights the salient characteristics of SLNs and NLCs concerning ocular drug delivery, and updates the research progress in this area.

15 February 2018 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Velichka AndonovaVelichka Andonova
Velichka Andonova
PPPetya Peneva
Petya Peneva
Background: Solid lipid nanoparticles (SLN) and the next generation of nanostructured lipid carriers (NLC) seem to be a very promising alternative to other colloidal carriers, such as liposomes, microemulsions, and polymeric nanoparticles. These combine the advantages of the cited nanocarriers and can improve the dissolution rate in biological fluids, increase the drug absorption, improve the tissue distribution in the target organ, enhance the drug bioavailability and ensure controlled drug release. SLN and NLC can ensure higher drug stability in the harsh environment, cover the bitter taste of the drug, and reduce the first-pass effect after oral administration. However, these carriers suffer from some disadvantages such as low drug loading capacity, drug expulsion, and unpredictable gelation tendency. Methods: This article aims to provide detail information about the process of complex characterization of SLN and NLC to produce an effective, quality and safe colloidal DDS with desired properties, based on the literature published in the period from 2000 to 2017. Results: Characterization techniques in terms of size and particle size distribution; surface morphology, functionalization, and zeta potential; structure, depending on the degree of crystallinity, lipid modification, drug incorporation and loading capacity; drug release; co-existence of other nano- and microstructures; and toxicity assessment according to the process of production, lipids and surfactants used and route of administration are discussed in the article. Conclusion: The precise characterization of lipid nanocarriers as drug delivery systems ensures guarantees for the quality of the product as an effective and safe form. The typical composition of SLN and NLC requires a comprehensive approach of characterization and in-depth analysis of the results to perform a drug delivery system with desired properties.

2 August 2017 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
Velichka AndonovaVelichka Andonova
Velichka Andonova
PPPetya T. Peneva
Petya T. Peneva
EAElisaveta G. Apostolova
Elisaveta G. Apostolova
TDTeodora D. Dimcheva
Teodora D. Dimcheva
ZPZhivko L. Peychev
Zhivko L. Peychev
MKMargarita I. Kassarova
Margarita I. Kassarova
Carbopol hydrogel/sorbitan monostearate-almond oil based organogel biphasic formulations: Preparation and characterization of the bigels

24 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Viliana GuglevaViliana Gugleva
Viliana Gugleva
Nadezhda IvanovaNadezhda Ivanova
Nadezhda Ivanova
YSYoana Sotirova
Yoana Sotirova
Velichka AndonovaVelichka Andonova
Velichka Andonova
Phenolic compounds are a large, heterogeneous group of secondary metabolites found in various plants and herbal substances. From the perspective of dermatology, the most important benefits for human health are their pharmacological effects on oxidation processes, inflammation, vascular pathology, immune response, precancerous and oncological lesions or formations, and microbial growth. Because the nature of phenolic compounds is designed to fit the phytochemical needs of plants and not the biopharmaceutical requirements for a specific route of delivery (dermal or other), their utilization in cutaneous formulations sets challenges to drug development. These are encountered often due to insufficient water solubility, high molecular weight and low permeation and/or high reactivity (inherent for the set of representatives) and subsequent chemical/photochemical instability and ionizability. The inclusion of phenolic phytochemicals in lipid-based nanocarriers (such as nanoemulsions, liposomes and solid lipid nanoparticles) is so far recognized as a strategic physico-chemical approach to improve their in situ stability and introduction to the skin barriers, with a view to enhance bioavailability and therapeutic potency. This current review is focused on recent advances and achievements in this area.